Editas Medicine, Inc. Share Price
NASDAQ: EDIT | Micro CapEditas Medicine, Inc. Stock Performance
Editas Medicine, Inc. Share Price Today
As of 30 October 2026, Editas Medicine, Inc.'s share price is $2.93. The stock opened at $2.94, compared to its previous close of $2.94. During today's trading session, Editas Medicine, Inc.'s share price traded between $2.87 and $2.98, with an average price of $2.92. Over the past 52 weeks, the stock has recorded a high of $3.94 and a low of $1.66. In terms of performance, Editas Medicine, Inc.'s share price has declined by 2.33% over the last six months and is down 4.56% on a year-on-year basis.
Editas Medicine, Inc. Share Price Chart
Editas Medicine, Inc. Quarterly Profit & Loss
All figures in USD
Editas Medicine, Inc. Annual Profit & Loss
All figures in USD
About Editas Medicine, Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
Editas Medicine, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.61 | $2.92 | +13.59% |
Sep 2026 | $3.02 | $2.58 | -21.97% |
Aug 2026 | $2.58 | $3.30 | +28.40% |
Jul 2026 | $3.33 | $2.57 | -20.56% |
Jun 2026 | $3.33 | $3.23 | -6.37% |
May 2026 | $2.98 | $3.46 | +15.17% |
Apr 2026 | $2.61 | $3.00 | +21.21% |
Mar 2026 | $2.10 | $2.48 | +12.24% |
Feb 2026 | $1.98 | $2.21 | +11.36% |
Jan 2026 | $2.07 | $1.98 | -3.65% |
Dec 2025 | $2.36 | $2.06 | -14.37% |
Nov 2025 | $3.02 | $2.40 | -21.82% |